Exercise for Arthritis
(DREAM Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how varying amounts of exercise can alleviate arthritis symptoms. Participants will exercise for 45, 90, or 150 minutes a week to determine which duration provides the most relief. It suits individuals diagnosed by a doctor with arthritis, rheumatoid arthritis, gout, lupus, or fibromyalgia who are not currently engaging in much exercise. As an unphased trial, this study offers a unique opportunity to enhance understanding of exercise benefits for arthritis.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this exercise protocol is safe for arthritis patients?
Research has shown that exercise is generally safe and beneficial for people with arthritis. Studies have found that physical activity can reduce pain and improve mobility, while also helping to prevent other health issues. A review of multiple studies found that exercise programs led to moderate improvements in activity levels and small reductions in pain for people with arthritis.
The DREAM Adaptive Intervention provides a personalized exercise plan designed for safety. It allows participants to adjust their activity levels based on their capabilities. Overall, regular exercise is well-tolerated and poses a low risk for most people with arthritis.12345Why are researchers excited about this trial?
Researchers are excited about the "Exercise for Arthritis" trial because it explores how different levels of physical activity might benefit people with arthritis. Unlike standard treatments, which often include medications like NSAIDs and DMARDs to manage pain and inflammation, this trial focuses on the potential of exercise as a direct intervention. The trial tests three specific exercise goals — 45, 90, and 150 minutes per week of moderate-to-vigorous activity — to determine which amount provides the best relief. This approach is unique because it examines exercise as a tailored prescription, potentially offering a natural, non-pharmaceutical way to manage arthritis symptoms.
What evidence suggests that this trial's treatments could be effective for arthritis?
Studies have shown that exercise programs can greatly benefit people with arthritis. Research indicates that regular physical activity reduces pain and improves mobility. In this trial, participants will follow different exercise goals within the DREAM Adaptive Intervention, which focuses on moderate-to-vigorous exercise. This type of exercise has been linked to healthier joints and reduced arthritis pain. Many participants in similar programs have experienced noticeable pain relief within one month of starting their exercise routine. This evidence suggests that regular exercise, as in the DREAM program, can effectively manage arthritis symptoms.16789
Who Is on the Research Team?
Christine Pellegrini, PhD
Principal Investigator
University of South Carolina
Are You a Good Fit for This Trial?
This trial is for individuals with various forms of arthritis or related conditions, such as Fibromyalgia, Lupus, and Rheumatoid Arthritis. Participants should be able to perform physical activity and are looking to manage their symptoms through exercise.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a physical activity program with goals of 45, 90, or 150 minutes per week for 6 months, supported by the Arthritis Foundation's Walk With Ease Guidebook, behavioral lessons, a Fitbit, and monthly coaching calls.
Follow-up
Participants are monitored for changes in physical function, quality of life, pain intensity, and depression symptoms.
Long-term Follow-up
Participants are further monitored for changes in physical function and pain intensity.
What Are the Treatments Tested in This Trial?
Interventions
- DREAM Adaptive Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of South Carolina
Lead Sponsor
Centers for Disease Control and Prevention
Collaborator